171 related articles for article (PubMed ID: 3840268)
1. Respiratory distress syndrome treated with human surfactant: radiographic findings.
Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
[TBL] [Abstract][Full Text] [Related]
2. Chest radiographic course after exogenous surfactant therapy in baboons with respiratory distress syndrome.
Shimada S; Raju TN; Vidyasagar D; Maeta H; Bhat R
Crit Care Med; 1990 Sep; 18(9):969-73. PubMed ID: 2394121
[TBL] [Abstract][Full Text] [Related]
3. The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome.
Odita JC
Pediatr Radiol; 2001 Feb; 31(2):87-91. PubMed ID: 11214692
[TBL] [Abstract][Full Text] [Related]
4. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Levine D; Edwards DK; Merritt TA
AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
[TBL] [Abstract][Full Text] [Related]
5. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
6. The effect of surfactant replacement therapy on conditions associated with respiratory distress syndrome: patent ductus arteriosus, intraventricular hemorrhage, and bronchopulmonary dysplasia.
Kendig JW; Sinkin RA
Semin Perinatol; 1988 Jul; 12(3):255-8. PubMed ID: 3041608
[TBL] [Abstract][Full Text] [Related]
7. Patent ductus arteriosus and respiratory outcome in premature infants.
Bancalari E; Claure N; Gonzalez A
Biol Neonate; 2005; 88(3):192-201. PubMed ID: 16210841
[TBL] [Abstract][Full Text] [Related]
8. Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.
Noack G; Berggren P; Curstedt T; Grossmann G; Herin P; Mortensson W; Nilsson R; Robertson B
Acta Paediatr Scand; 1987 Sep; 76(5):697-705. PubMed ID: 3661171
[TBL] [Abstract][Full Text] [Related]
9. Exogenous surfactant for treatment of respiratory distress syndrome in premature infants.
Chen JY
J Formos Med Assoc; 1990 Feb; 89(2):110-4. PubMed ID: 1973717
[TBL] [Abstract][Full Text] [Related]
10. Patent ductus arteriosus in preterm infants with idiopathic respiratory distress syndrome. Radiographic and echocardiographic evaluation.
Higgins CB; Rausch J; Friedman WF; Hirschklau MJ; Kirkpatrick SE; Goergen TG; Reinke RT
Radiology; 1977 Jul; 124(1):189-95. PubMed ID: 866638
[TBL] [Abstract][Full Text] [Related]
11. Management of preterm infants receiving surfactant supplementation.
Bevilacqua G; Gaioni L; Parmigiani S
Eur Respir J Suppl; 1989 Mar; 3():87s-90s. PubMed ID: 2742686
[TBL] [Abstract][Full Text] [Related]
12. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome.
Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN
N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150
[TBL] [Abstract][Full Text] [Related]
13. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study].
Shinwell ES; Zmora E; Leven D; Berger I; Karplus M
Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835
[TBL] [Abstract][Full Text] [Related]
14. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome.
Charon A; Taeusch W; Fitzgibbon C; Smith GB; Treves ST; Phelps DS
Pediatrics; 1989 Mar; 83(3):348-54. PubMed ID: 2919139
[TBL] [Abstract][Full Text] [Related]
16. Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome.
Dinger J; Schwarze R; Rupprecht E
Pediatr Radiol; 1997 Jan; 27(1):26-31. PubMed ID: 8995163
[TBL] [Abstract][Full Text] [Related]
17. Surfactant and respiratory distress syndrome.
Milner AD
Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
[TBL] [Abstract][Full Text] [Related]
18. Surfactant administration without intubation in preterm infants with respiratory distress syndrome--our experiences.
Krajewski P; Chudzik A; Strzałko-Głoskowska B; Górska M; Kmiecik M; Więckowska K; Mesjasz A; Sieroszewski P
J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1161-4. PubMed ID: 25065621
[TBL] [Abstract][Full Text] [Related]
19. Respiratory distress syndrome (hyaline membrane disease).
Ablow RC
Crit Rev Diagn Imaging; 1981; 14(4):321-63. PubMed ID: 7021069
[TBL] [Abstract][Full Text] [Related]
20. Findings on chest radiographs after prophylactic pulmonary surfactant treatment of premature infants.
Clarke EA; Siegle RL; Gong AK
AJR Am J Roentgenol; 1989 Oct; 153(4):799-802. PubMed ID: 2773736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
